Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial
Titel:
Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial
Auteur:
Mateos, Maria-Victoria San-Miguel, Jesus Cavo, Michele Suzuki, Kenshi Jakubowiak, Andrzej Knop, Stefan Doyen, Chantal Lucio, Paulo Nagy, Zsolt Pour, Ludek Grosicki, Sebastian Crepaldi, Andre Liberati, Anna Marina Campbell, Philip Yoon, Sung-Soo Iosava, Genadi Fujisaki, Tomoaki Garg, Mamta Ngo, Mai Katz, Eva G Krevvata, Maria Bolyard, Kasey Carson, Robin Borgsten, Fredrik Dimopoulos, Meletios A